Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Blood Neoplasia|June 24, 2025
Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignanciesLawrence A Stern, Vibhuti Vyas, Laura Lim, et al.Cancer Research|February 5, 2024
Immunometabolic Adaptation of CD19-Targeted CAR T Cells in the Central Nervous System Microenvironment of Patients Promotes Memory DevelopmentLior Goldberg, Eric R Haas, Ryan Urak, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2014
Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacyMahesh Jonnalagadda, Armen Mardiros, Ryan Urak, et al.Cancer Immunology Research|March 21, 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Robyn A Wong, Xin Yang, et al.Journal for Immunotherapy of Cancer|January 14, 2022
Large-scale manufacturing and characterization of CMV-CD19CAR T cellsXiuli Wang, Ryan Urak, Miriam Walter, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2023
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expressionAshlie M Munoz, Ryan Urak, Ellie Taus, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple MyelomaXiuli Wang, Miriam Walter, Ryan Urak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2015
CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T CellsXiuli Wang, ChingLam W Wong, Ryan Urak, et al.Oncoimmunology|January 9, 2018
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancerSaul J Priceman, Ethan A Gerdts, Dileshni Tilakawardane, et al.Journal for Immunotherapy of Cancer|August 11, 2025
Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumorsAnthony K Park, Isabel Monroy, Yuwei Ren, et al.Pageof 3